“…Four decades ago, when IR is discovered, it revealed new insights of its role in regulation of gene expression, pathogenesis, and treatment approaches (Kumari et al, 2022). Researchers have been captivated in carrying out pre-clinical and clinical trials on new drug molecules to either interfere, inhibit, or alter the spliceosome itself or the splicing reactions to treat various spliceopathies (Rupaimoole and Slack, 2017;Bonnal et al, 2020;Desterro et al, 2020;Steensma et al, 2021;Childs-Disney et al, 2022;Murphy et al, 2022;Qin et al, 2022;Suresh et al, 2022;Zhu et al, 2022;Velema and Lu, 2023). It is worth noting that IR can be used as a diagnostic biomarker for the intronic expansion disorders in addition to its applications for therapeutic purposes (Sznajder et al, 2018).…”